The strongest clinical evidence in all of cannabis medicine concerns seizures: Epidiolex, a purified CBD medication, is FDA-approved for Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. State programs provide access to broader cannabinoid formulations under physician supervision.
Seizure patients should never replace prescribed anticonvulsants with cannabis without neurologist involvement — abrupt changes can be dangerous. Certification physicians will typically coordinate with or defer to your treating neurologist.
Minor patients with epilepsy are a significant population in many programs; caregiver registration rules apply.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law.